Close

IMRIS CFO to Present at Canaccord Cardiovascular Conference

December 5, 2011 10:41 AM EST
This is a test header.

WINNIPEG, Dec. 5, 2011 /PRNewswire/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Company") today announced that Kelly McNeill, IMRIS Chief Financial Officer will present at the Canaccord Genuity Cardiovascular, Aesthetics & Metabolic Disorders Conference on December 6, 2011 at 3:00 pm Pacific Time. An audio webcast of Mr. McNeill's presentation will be available at www.imris.com.

About IMRIS

IMRIS (NASDAQ: IMRS; TSX: IM) is a global leader in providing image guided therapy solutions through its VISIUS Surgical Theatre - a revolutionary, multifunctional surgical environment that provides unmatched intraoperative vision to clinicians to assist in decision making and enhance precision in treatment. VISIUS Surgical Theatres serve the neurosurgical, cardiovascular and cerebrovascular markets and have been selected by leading medical institutions around the world.

SOURCE IMRIS Inc.



Are you missing key trading opportunities? Upgrade to StreetInsider Premium and get a step ahead of the market - FREE TRIAL!





Related Categories

Press Releases

Related Entities

Genuity Capital Markets